Affiliation:
1. Department of Cardiothoracic Surgery, Changzheng Hospital, Naval Medical University
Abstract
Abstract
Background
Clinical studies have shown that cardiovascular diseases in patients with type 1 diabetes (T1D) are often atypical or asymptomatic. While diabetic cardiomyopathy has been confirmed, the link between T1D and arrhythmia remains unclear. To infer causality between T1D and arrhythmia at the genetic level, we conducted a Mendelian randomization study through the genetic tools of T1D.
Methods
In this study, we used genetic variables and summary statistics from genome-wide association studies (GWAS) of type 1 diabetes (T1D) and arrhythmia. Single nucleotide polymorphisms (SNPs) were selected based on the assumptions of instrumental variables (IVs). The inverse variance-weighted (IVW) method was used as the primary analysis to summarize the causal effects between exposure and outcome. The weighted median and weighted mode methods were used as secondary methods. We tested for horizontal pleiotropy using the MR-Egger method and detected heterogeneity using the Q-test. A leave-one-out sensitivity analysis was performed. Scatter plots, forest plots, and funnel plots were used to visualize the results of the MR analysis.
Results
In this study, we selected 28 T1D-related SNPs as instrumental variables. The IVW [odds ratio (OR) = 0.98, 95% confidence interval (CI) = 0.97 − 1.00, P = 0.008], weighted median (OR = 0.98, 95% CI = 0.96 − 0.99, P = 0.009), and weighted mode (OR = 0.98, 95% CI = 0.96 − 0.99, P = 0.018) analysis methods suggested a causal effect of T1D on arrhythmia. The MR-Egger method indicated no horizontal pleiotropy (P = 0.649), and the Q-test showed no heterogeneity (IVW, P = 0.653). Sensitivity analysis indicated that the MR analysis results were robust.
Conclusions
Our MR analysis revealed a causal association between T1D and the development of arrhythmia, indicating that patients with T1D had a higher risk of arrhythmia.
Publisher
Research Square Platform LLC
Reference37 articles.
1. Estimation of Annual Health Care Costs for Adults with Type 1 Diabetes in the United States;Joish VN;J Manag Care Spec Pharm,2020
2. 18553/jmcp. 2020.26.3.311.
3. Gregory G, Robinson T, Linklater S, Wang F, Colagiuri S, de Beaufort C et al. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. The lancet Diabetes & endocrinology. 2022;10(10):741 – 60. doi: 0.06/s223-8587(22)0028-2.
4. Vanderniet JA, Jenkins AJ, Donaghue KC. Epidemiology of Type 1 Diabetes. Curr Cardiol Rep. 2022;24(10):1455-65. doi: 0.007/s886-022-0762-w.
5. Association of hypoglycaemia and risk of cardiac arrhythmia in patients with diabetes mellitus: A systematic review and meta-analysis;Fitzpatrick C;Diabetes Obes Metab,2018